Lv7
4980 积分 2021-08-23 加入
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease
9天前
已完结
Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis
9天前
已完结
Expanding the binding space of argonaute-2: incorporation of either E or Z isomers of 6′-vinylphosphonate at the 5′ end of the antisense strand improves RNAi activity
14天前
已完结
Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic Tractability
18天前
已完结
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for Fibrosis
18天前
已完结
Total Synthesis of Enlicitide Decanoate
1个月前
已完结
Sulfonyl hydrazides as a general redox-neutral platform for radical cross-coupling
1个月前
已完结
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder
1个月前
已完结
Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy
1个月前
已完结
Trivalent siRNA-Conjugates with Guanosine as ASGPR-Binder Show Potent Knock-Down In Vivo
1个月前
已完结
皖公网安备34019202002308
